Body Contouring in Cedar Rapids Iowa
Body Contouring in Cedar Rapids section, includes general infrmation about Body Contouring Procedure, Body Contouring Cedar Rapids Local News, Body Contouring Cedar Rapids Surgeon Locator and other Body Contouring related material.
Cedar Rapids Body Contouring - The Procedure
This procedure can help you to dramatically improve your appearance. It is usually the next step after excessive weight reduction or bariatric surgery. When you loose weight quickly your skin cannot return to the new size as quickly resulting in extra skin is areas such as the abdomen, upper arms, thighs and breasts. Sometimes your skin is not elastic enough due to aging process, which can lead to permanent skin flaps. It can also be done to repair the effects of childbearing and aging. The extra skin can cause hygiene problems, avoiding cloth with short sleeves and low self-esteem. Body contouring is a series of operation, which can be divided into two groups, lower body lift and upper body lift. The lower body lift deals with your abdomen thighs and buttocks. Upper body lift is complementary to the lower body lift and it deals with breast and upper arms. The ideal candidates for the surgery are people in good general health who are unsatisfied with their body appearance.
Cedar Rapids Body Contouring - OperationDuring the surgery usually the abdomen is treated first, because it is the area with the most excess of skin and fat. A horizontal incision is made above the pubic area, through which the extra fat is removed and the muscles are tightened. In some cases liposuction is performed to remove extra fat. Thighs and butt are treated by the same principle. The operation lasts from 4-7 hours and performed under general anesthesia. Sometimes additional procedures are done during the same operation; those include breast lift, arm lift or inner thigh lift. Arm lift is done by placing an incision from the armpit to the elbow and by removing extra fat and skin. The excess fat from the inner thigh is removed by liposuction, the incision usually made between the groin and the upper thigh.
Cedar Rapids Body Contouring - Risks
Every procedure has its risks. The most common complication of body lift is seroma formation. Other complications such as bleeding, infection or blood clots are relatively rare. The scars never completely disappear, but they fade with time and change their size. This can take several months until the scars take their final appearance.
Cedar Rapids Body Contouring - Healing
This is a serious procedure, which takes some time to heal. Many people require 4-6 weeks before returning to their daily activities. You shouldn't exercise or lift heavy weight 6-8 weeks. The swelling usually completely disappears after 3 month. It is important to wear special garments to assure proper healing.
Other Body Contouring Procedures
All Body Procedures
Body Contouring cedar-rapids (current)
cedar-rapids Buttock Augmentation
cedar-rapids Calf Augmentation
cedar-rapids Liposuction
cedar-rapids Body Contouring
More Cedar Rapids info...
Cedar Rapids See
Cedar Rapids Downtown District [2]
Cedar Rapids History Center [3]
Cedar Rapids Museum of Art, 410 Third Avenue SE, +1 319 366-7503 [4] Features a collections of works by Iowa natives Grant Wood and Marvin Cone, along with a collection of 21 Roman portrait busts.
Science Station, 427 First St. SE, +1 319 366-0968 [5] Interactive children's science museum. Features an IMAX dome.
Cedar Rapids Drink
Cedar Brewing Company [10], 500 Blairs Ferry Road NE, +1 319 378-9090. A microbrewery.
Plastic Surgery News...
- According to research published in Diabetes Care, insulin aspart is as safe and effective as insulin lispro for use in a continuous subcutaneous insulin infusion (CSII) in children and adolescents with type 1 diabetes.
Researchers evaluated the safety and efficacy of insulin aspart CSII compared with that of insulin lispro CSII in children and adolescents with type 1 diabetes. The study involved 298 children and adolescents aged 4 to 18 years, who were randomised to receive 16 weeks of insulin aspart CSII (n=198) or insulin lispro CSII (n=100).
The researchers reported that after 16 weeks of treatment, insulin aspart CSII was non-inferior to insulin lispro CSII as measured by change in HbA1C from baseline (aspart, –0.15 +/- 0.05%; lispro, –0.05 +/- 0.07% [95% CI of the treatment difference –0.27 to 0.07]; P = 0.241). Additionally, the following results were reported:
• At week 16, 59.7% of subjects in the aspart group and 43.8% of subjects in the lispro groups achieved age-specific American Diabetes Association A1C goals (<8.5% for subjects aged <6 years; <8% for subjects aged 6–18 years) (P = 0.040, corrected for baseline).
• No significant differences between treatment groups were observed in fasting plasma glucose, hyperglycaemia, and rates of hypoglycaemic episodes.
• Daily insulin dose (units per kilogram) was statistically significantly lower at week 16 for subjects treated with aspart compared with those treated with lispro (0.86 ± 0.237 vs. 0.94 ± 0.233, P = 0.018).
- The Department of Health’s (DoH) response to the Public Accounts Committee's report on 'Prescribing costs in primary care' has been published.
In the publication, the DoH notes that around a quarter of all expenditure in primary care is on drugs, and both the volume of drugs prescribed and their total cost are increasing. The DoH states that the NHS could save more than £200 million a year, without affecting patient care, by GPs prescribing lower cost but equally effective medicines, and that generic products should be used instead of branded equivalents (however, this is based on data which is over 2 years old).
In response to the PAC finding that prescription costs for treatment of some common conditions varies between PCTs, the DoH agrees that Strategic Health Authorities (SHAs) should work with the National Prescribing Centre to spread best practice in prescribing and help those PCTs that have difficulty implementing switching programmes to learn from PCTs that have successfully done so.
In response to the differences in prescribing choices between primary and secondary care, the DoH agrees that SHAs should work with the National Prescribing Centre to promote agreement and consistency of formularies across primary and secondary care, and across PCTs.
For full details of recommendations, please see link above.